Nanopath
Point-of-care diagnostics company enabling molecular testing for women's health.
Cambridge, MA
Funding event
The round itself, as filedStage · pressSeries B
Amount sold$25.0M
Filed2026-11-10
Days since filing3
Investors · press-matched
NorwestSV Health Investors' MedTech Convergence FundLabcorp Venture FundElderberry VenturesGingerBread CapitalAlumni VenturesPress release
Form D does not name investors; these come from the matched release, as a fact with a link.
Officers on the filing
Names and roles as filed; addresses are never storedNo officers named on this filing.
Health flags
Three flags, each with the raw inputs behind itNot computed yet for this company.
Open roles
On the employer's own careers page · check date not recorded0
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.